相关实验视频

Updated: Jul 4, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

对鼻腔NUT癌的治疗方法:系统性审查

Anastasia Urbanelli¹, Letizia Nitro², Carlotta Pipolo²

¹Department of Surgical Sciences, Otorhinolaryngology Unit, University of Turin, Via G. Verdi, 8, 10124, Turin, Italy. anastasia.urbanelli@gmail.com.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

|February 8, 2024

概括

丸癌中的鼻腔核蛋白 (SNUTC) 是一种罕见的癌症. 这项审查发现,手术后进行放射化疗是一种常见的治疗方法,但由于结果不佳,需要个性化策略.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
癌症研究癌症研究

背景情况:

丸癌中的鼻腔核蛋白 (SNUTC) 是一种罕见且具有攻击性的恶性瘤.
它的特点是NUTM1基因中的遗传重组.
SNUTC的预后非常差,平均存活时间为9.7个月.

研究的目的:

系统地审查文献,并确定SNUTC的最佳治疗策略.
分析诊断为SNUTC的患者的治疗结果.

主要方法:

对符合条件的文章进行了系统审查.
提取的数据包括患者人口统计,TNM分期,治疗反应,生存时间 (OS) 和随后的治疗.
分析重点是17项报告25名患者治疗数据的研究.

主要成果:

手术作为主要治疗,其次是联合放射化疗作为二线或辅助疗法是最常见的治疗方案.
大多数被纳入的研究 (12/17) 是病例报告.
在随访期间,只有四名患者存活下来.

结论:

目前的文献中尚未建立SNUTC的标准化治疗方案.
建议针对个人SNUTC患者量身定制的个性化治疗方法.
需要进一步的研究来确定这种罕见的癌症的有效治疗策略.

关键词:

头部和部瘤头部和部瘤在NUT中线癌瘤中.丸中的核蛋白是瘤癌.鼻性NUT癌瘤是一种癌症.鼻恶性瘤是一种恶性瘤.

更多相关视频

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...